Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
Clinical trial NCT05171946 · UNKNOWN
Trial details
- NCT number
- NCT05171946
- Sponsor
- Iman Almansour
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-20
- Primary completion
- 2023-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.